BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  CMUH and Shine-On Biomedical Lead Taiwan’s Push into Global Exosome-Based Precision Medicine

  June 26, 2025

   · 

  3 min read
• Press Releases

  Viatris Announces Positive Top-Line Results from Second Pivotal Phase 3 VEGA-3 Trial of MR-141 in Presbyopia

  June 26, 2025

   · 

  7 min read
• Press Releases

  Aldeyra Therapeutics Receives Special Protocol Assessment Agreement Letter from the U.S. Food and Drug Administration for ADX-2191 for the Treatment of Primary Vitreoretinal Lymphoma

  June 26, 2025

   · 

  8 min read
• Press Releases

  KalVista Pharmaceuticals Enters into Licensing Agreement with Pendopharm to Commercialize Sebetralstat for HAE in Canada

  June 26, 2025

   · 

  4 min read
• Press Releases

  ZyVersa Therapeutics Announces First Clinical Site Activation, Initiating Patient Recruitment for Cholesterol Efflux Mediator™ VAR 200’s Phase 2a Clinical Trial in Patients with Diabetic Kidney Disease (DKD)

  June 26, 2025

   · 

  6 min read
• Press Releases

  Positive Preliminary Cohort B Results from the AGITG-led ASCEND Trial to be Presented at ESMO GI Evaluating Lisata’s Certepetide in Combination with Standard-of-Care Chemotherapy in Metastatic Pancreatic Cancer

  June 26, 2025

   · 

  10 min read
• Press Releases

  Annovis to Attend the AAIC 2025 with Four Poster Presentations

  June 26, 2025

   · 

  2 min read
• Press Releases

  CIRCA Scientific Announces Successful Completion of Limited Market Release for CrossWise™ RF Transseptal Access System and Expands Compatibility to Additional Sheaths

  June 26, 2025

   · 

  3 min read
• Press Releases

  Alebund Announces Positive Topline Results from Pivotal Phase 3 Study of AP301 for Serum Phosphorus Control in Dialysis Patients with Hyperphosphatemia

  June 26, 2025

   · 

  4 min read
• Press Releases

  Pint Pharma Announces INVIMA’s Approval of ORLADEYO® (berotralstat), the First Oral Therapy for Preventing Hereditary Angioedema (HAE) Attacks in Patients Aged 12 and Older in Colombia

  June 26, 2025

   · 

  2 min read